Literature DB >> 7772650

Specific IgA antibody increases in schizophrenia.

K L Reichelt1, J Landmark.   

Abstract

IgA antibody levels in serum were examined in two groups of schizophrenic patients. All were diagnosed according to DSM-III-R criteria. One group of 36 males and 12 females were compared to historical controls. The other group consisted of 13 males off drugs for at least 3 months; these were compared with age- and sex-matched controls. An increase in specific IgA antibodies was found. More schizophrenics than controls showed IgA antibody levels above the upper normal limit to gliadin, beta-lactoglobulin, and casein.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7772650     DOI： 10.1016/0006-3223(94)00176-4

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


  24 in total

1.  Kynurenine and Tryptophan Levels in Patients With Schizophrenia and Elevated Antigliadin Immunoglobulin G Antibodies.

Authors:  Olaoluwa Okusaga; Dietmar Fuchs; Gloria Reeves; Ina Giegling; Annette M Hartmann; Bettina Konte; Marion Friedl; Maureen Groer; Thomas B Cook; Kelly A Stearns-Yoder; Janardan P Pandey; Deanna L Kelly; Andrew J Hoisington; Christopher A Lowry; William W Eaton; Lisa A Brenner; Dan Rujescu; Teodor T Postolache
Journal:  Psychosom Med       Date:  2016-10       Impact factor: 4.312

Review 2.  Gluten- and casein-free diets for autistic spectrum disorder.

Authors:  C Millward; M Ferriter; S Calver; G Connell-Jones
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

3.  Gastrointestinal inflammation and associated immune activation in schizophrenia.

Authors:  Emily G Severance; Armin Alaedini; Shuojia Yang; Meredith Halling; Kristin L Gressitt; Cassie R Stallings; Andrea E Origoni; Crystal Vaughan; Sunil Khushalani; F Markus Leweke; Faith B Dickerson; Robert H Yolken
Journal:  Schizophr Res       Date:  2012-03-24       Impact factor: 4.939

4.  Complement C1q formation of immune complexes with milk caseins and wheat glutens in schizophrenia.

Authors:  Emily G Severance; Kristin L Gressitt; Meredith Halling; Cassie R Stallings; Andrea E Origoni; Crystal Vaughan; Sunil Khushalani; Armin Alaedini; Didier Dupont; Faith B Dickerson; Robert H Yolken
Journal:  Neurobiol Dis       Date:  2012-07-16       Impact factor: 5.996

5.  Gluten sensitivity and relationship to psychiatric symptoms in people with schizophrenia.

Authors:  Jessica Jackson; William Eaton; Nicola Cascella; Alessio Fasano; Debby Santora; Kelli Sullivan; Stephanie Feldman; Heather Raley; Robert P McMahon; William T Carpenter; Haley Demyanovich; Deanna L Kelly
Journal:  Schizophr Res       Date:  2014-10-11       Impact factor: 4.939

6.  Association between schizophrenia and an autoimmune bullous skin disease-pemphigus: a population-based large-scale study.

Authors:  K Kridin; S Zelber-Sagi; D Comaneshter; A D Cohen
Journal:  Epidemiol Psychiatr Sci       Date:  2017-09-25       Impact factor: 6.892

7.  Search for schizophrenia susceptibility variants at the HLA-DRB1 locus among a British population.

Authors:  Lorna Halley; Mary K Doherty; Ian L Megson; Neil McNamara; Andy Gadja; Jun Wei
Journal:  Immunogenetics       Date:  2012-09-29       Impact factor: 2.846

Review 8.  Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity.

Authors:  Jessica R Jackson; William W Eaton; Nicola G Cascella; Alessio Fasano; Deanna L Kelly
Journal:  Psychiatr Q       Date:  2012-03

9.  Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population.

Authors:  Nicola G Cascella; Debra Kryszak; Bushra Bhatti; Patricia Gregory; Deanna L Kelly; Joseph P Mc Evoy; Alessio Fasano; William W Eaton
Journal:  Schizophr Bull       Date:  2009-06-03       Impact factor: 9.306

Review 10.  Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling.

Authors:  Emily G Severance; Robert H Yolken; William W Eaton
Journal:  Schizophr Res       Date:  2014-07-15       Impact factor: 4.939
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.